Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.860
-0.070 (-3.63%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems.

It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems.

In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices.

Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices.

It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Stereotaxis, Inc.
Stereotaxis logo
Country United States
Founded 1990
IPO Date Aug 12, 2004
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 131
CEO David Fischel

Contact Details

Address:
710 North Tucker Boulevard, Suite 110
Saint Louis, Missouri 63101
United States
Phone 314 678 6100
Website stereotaxis.com

Stock Details

Ticker Symbol STXS
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001289340
CUSIP Number 85916J409
ISIN Number US85916J4094
Employer ID 94-3120386
SIC Code 3845

Key Executives

Name Position
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. Chief Executive Officer and Chairman
Kimberly R. Peery CPA Chief Financial Officer
Keith Galloway Vice President of Operations
Patricia S. Williams Esq. General Counsel and Secretary

Latest SEC Filings

Date Type Title
Apr 15, 2026 8-K Current Report
Apr 3, 2026 10-K/A [Amend] Annual report
Apr 3, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 3, 2026 DEF 14A Other definitive proxy statements
Mar 20, 2026 EFFECT Notice of Effectiveness
Mar 13, 2026 S-3 Registration statement under Securities Act of 1933
Mar 12, 2026 10-K Annual Report
Mar 9, 2026 8-K Current Report
Nov 12, 2025 10-Q Quarterly Report
Nov 12, 2025 8-K Current Report